Non-infectious pulmonary toxicity of rituximab: a systematic review

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

(2010) Francisco Javier Peñalver et al.   ANNALS OF HEMATOLOGY

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab

(2010) U. Disel et al.   CHEMOTHERAPY

Biologics in the treatment of systemic lupus erythematosus

(2010) Aisha Lateef et al.   CURRENT OPINION IN RHEUMATOLOGY

Rituximab-induced fatal interstitial pneumonitis: case report

(2010) C. Vulsteke et al.   LEUKEMIA & LYMPHOMA

Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma

(2010) Hiroo Katsuya et al.   LEUKEMIA & LYMPHOMA

The future of CD20 monoclonal antibody therapy in B-cell malignancies

(2010) Myron S. Czuczman et al.   LEUKEMIA & LYMPHOMA

Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience

(2010) A. Lateef et al.   LUPUS

B cells as therapeutic targets in SLE

(2010) Iñaki Sanz et al.   Nature Reviews Rheumatology

Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab

(2010) Kyu-Hyoung Lim et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Rituximab Therapy in Primary Sjögren's Syndrome

(2009) Cristina Alcântara et al.   Annals of the New York Academy of Sciences

Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment

(2009) J M Meijer et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab-induced lung disease: a systematic literature review

(2009) H. Liote et al.   EUROPEAN RESPIRATORY JOURNAL

[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy

(2009) Dimitrios Kalkanis et al.   LEUKEMIA & LYMPHOMA

Fatal pulmonary fibrosis after rituximab administration

(2009) Marie-Camille Chaumais et al.   PEDIATRIC NEPHROLOGY

Rituximab (B-cell depleting antibody) associated lung injury (RALI): A pediatric case and systematic review of the literature

(2009) Martin Bitzan et al.   PEDIATRIC PULMONOLOGY

A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus

(2009) J. Kishi et al.   RHEUMATOLOGY

Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection

(2009) Thomas Fehr et al.   TRANSPLANTATION

Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin’s lymphoma

(2008) Tomohiko Yamane et al.   ANNALS OF NUCLEAR MEDICINE

Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma

(2008) Toshiki Kazama et al.   ANNALS OF NUCLEAR MEDICINE

Durable complete responses from therapy with combined epratuzumab and rituximab

(2008) John P. Leonard et al.   CANCER

A possible role of 18F-FDG positron-emission tomography scanning in the early detection of rituximab-induced pneumonitis in patients with non-Hodgkin's lymphoma

(2008) L. Nieuwenhuizen et al.   HAEMATOLOGICA

Increased incidence of interstitial pneumonia by CHOP combined with rituximab

(2008) Daisuke Ennishi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Organizing pneumonia after rituximab therapy: Two cases

(2008) Martin Soubrier et al.   JOINT BONE SPINE

Rituximab: A new therapeutic alternative in rheumatoid arthritis

(2008) Jean Sibilia et al.   JOINT BONE SPINE

Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma

(2008) Xin Liu et al.   LEUKEMIA & LYMPHOMA

Post‐marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab

(2008) V. González et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Rituximab-Induced Hypersensitivity Pneumonitis

(2008) Adriano R. Tonelli et al.   RESPIRATION

Rituximab-CHOP Induced Interstitial Pneumonitis in Patients with Disseminated Extranodal Marginal Zone B Cell Lymphoma

(2008) Kwang Min Kim et al.   YONSEI MEDICAL JOURNAL